Fraxiparine 2850IU Injection
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Salt Composition
Nadroparin (2850IU)
Overview Fraxiparine 2850IU Injection
Nadroparin calcium 2850 IU injection is an anticoagulant medication preventing and treating dangerous blood clots. This medication inhibits existing clot growth and prevents new clot formation in vital areas such as the legs, lungs, brain, and heart. Administration is solely by a healthcare professional (doctor or nurse). Dosage and treatment duration depend on individual factors including medical history, treatment goals, response to therapy, age, and weight. Continued injections are crucial, even without noticeable symptoms, as it actively prevents future complications. Discontinuation risks clot formation. Potential side effects include bleeding, injection site reactions, elevated liver enzymes, and hematomas at the injection site. Patients should minimize activities increasing bleeding risk and exercise caution with sharp objects (e.g., shaving, nail trimming). Prior to treatment, inform your physician of any pre-existing conditions like hypertension, diabetes, or recent stroke. This medication is contraindicated with active bleeding. Full disclosure of all other medications is necessary to ensure safe co-administration. Pregnant or breastfeeding individuals should consult their doctor before using Nadroparin calcium.
Uses of Fraxiparine 2850IU Injection
Preventing and managing blood clots
Major Benefits of Fraxiparine 2850IU Injection:
Administering this medication will be done by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Fraxiparine 2850IU Injection:
- Injection site reaction
- Bleeding
- Injection site hematoma
- Increased liver enzymes
How to use Fraxiparine 2850IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Fraxiparine 2850IU Injection works:
Clexane 2850 IU injection is a medication that inhibits blood clot development, reducing the risk of dangerous thrombi.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fraxiparine 2850IU Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Fraxiparine 2850 IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Fraxiparine 2850IU Injection while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Fraxiparine 2850IU Injection is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with severe renal impairment should use Nadroparin Calcium 2850 IU Injection cautiously. Dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Fraxiparine 2850IU Injection to individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Fraxiparine 2850IU Injection :
Omit a dose of Fraxiparine 2850IU Injection? Seek your physician's advice.
Facts to Know About Fraxiparine 2850IU Injection
| Label | Value |
|---|---|
| Chemical Category | Low-molecular-weight heparin |
| Developing Habits | No. |
| Type of Treatment | KINSHIP |
| Action Class | Low-molecular-weight heparin (LMWH) |
3,018 People bought this recently